Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex.

Xu XN, Purbhoo MA, Chen N, Mongkolsapaya J, Cox JH, Meier UC, Tafuro S, Dunbar PR, Sewell AK, Hourigan CS, Appay V, Cerundolo V, Burrows SR, McMichael AJ, Screaton GR.

Immunity. 2001 May;14(5):591-602.

2.

The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.

Kan-Mitchell J, Bisikirska B, Wong-Staal F, Schaubert KL, Bajcz M, Bereta M.

J Immunol. 2004 May 1;172(9):5249-61.

3.

The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.

Purbhoo MA, Boulter JM, Price DA, Vuidepot AL, Hourigan CS, Dunbar PR, Olson K, Dawson SJ, Phillips RE, Jakobsen BK, Bell JI, Sewell AK.

J Biol Chem. 2001 Aug 31;276(35):32786-92. Epub 2001 Jul 3.

4.

Stimulation of human cytotoxic T cells with HIV-1-derived peptides presented by recombinant HLA-A2 peptide complexes.

Walter JB, Brander C, Mammen M, Garboczi DN, Kalams SA, Whitesides GM, Walker BD, Eisen HN.

Int Immunol. 1997 Mar;9(3):451-9.

PMID:
9088983
5.

Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.

Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C.

Hum Immunol. 2004 May;65(5):514-22.

PMID:
15172452
7.

Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.

Puppo F, Contini P, Ghio M, Indiveri F.

ScientificWorldJournal. 2002 Feb 12;2:421-3. Review.

8.

Activation requirements of circulating antigen-specific human CD8(+) memory T cells probed with insect cell-based artificial antigen-presenting cells.

Guelly C, Küpcü Z, Zalusky D, Karner M, Zehetner M, Schweighoffer T.

Eur J Immunol. 2002 Jan;32(1):182-92.

9.

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.

Klenerman P, Rowland-Jones S, McAdam S, Edwards J, Daenke S, Lalloo D, Köppe B, Rosenberg W, Boyd D, Edwards A, et al.

Nature. 1994 Jun 2;369(6479):403-7.

PMID:
7515165
10.

Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.

McKinney DM, Skvoretz R, Livingston BD, Wilson CC, Anders M, Chesnut RW, Sette A, Essex M, Novitsky V, Newman MJ.

J Immunol. 2004 Aug 1;173(3):1941-50.

13.
14.
15.

[Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection].

Piao WH, He Y, Xi HL, Sun XT, Zhang HH, Xu JH, Zhao H, Xu WX, Li ZL, Wang GQ.

Zhonghua Yi Xue Za Zhi. 2004 Nov 2;84(21):1818-22. Chinese.

PMID:
15631781
16.

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

Nixon DF, Townsend AR, Elvin JG, Rizza CR, Gallwey J, McMichael AJ.

Nature. 1988 Dec 1;336(6198):484-7.

PMID:
2461519
17.
18.

Phenotypic analysis of antigen-specific T lymphocytes.

Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM.

Science. 1996 Oct 4;274(5284):94-6. Erratum in: Science 1998 Jun 19;280(5371):1821.

PMID:
8810254
20.

Supplemental Content

Support Center